Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.065 USD | +0.24% | +7.89% | -31.44% |
Mar. 25 | Esperion Shares Continue Rise After Friday's FDA Approval for Nexlizet, Nexletol | DJ |
Mar. 25 | Sector Update: Health Care Stocks Steady Premarket Monday | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-31.44% | 390M | |
+26.90% | 681B | |
+21.85% | 556B | |
-4.91% | 361B | |
+17.25% | 325B | |
+5.90% | 285B | |
+13.68% | 235B | |
+3.65% | 199B | |
-11.12% | 189B | |
-3.92% | 157B |
- Stock Market
- Equities
- ESPR Stock
- News Esperion Therapeutics, Inc.
- Northland Securities Downgrades Esperion Therapeutics to Underperform From Market Perform, Adjusts PT to $1 From $5